Mark Baldry, Chief Commercial Officer at X4 Pharmaceuticals, Inc (XFOR), sold 29,159 shares at $0.45 ($13K) on 2025-01-24, disclosed to the SEC on 2025-01-27.
Scheduled sale ($13k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| XFOR | SELL | 2023-11-03 | $7K | — | Filing → |